An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy
Clinical trial NCT00938912 · COMPLETED
Trial details
- NCT number
- NCT00938912
- Sponsor
- UCB BIOSCIENCES, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-09
- Primary completion
- 2021-05-18
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.